Citi Comments On GSK

According to Citi, GlaxoSmithKline GSK, Hold position is reiterated. Citi announced that they will be maintaining their Hold/Low-Risk position on GSK. PT is set at $41.17. GSK closed on Friday at $43.75
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorReiterationAnalyst RatingsCitiHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!